LB vs Ropivacaine for SPLS Recovery

Published: 12 March 2026| Version 1 | DOI: 10.17632/hdcm4pkk6w.1
Contributor:
Lingyu Wang

Description

Supplemental files for The Journal of Minimally Invasive Gynecology manuscript

Files

Steps to reproduce

This randomized, double-blind trial was conducted at Guangzhou Women and Children's Medical Center (Oct 2024–Oct 2025). Eighty patients undergoing gynecologic single-port laparoscopic surgery were randomly assigned to receive periumbilical infiltration with either liposomal bupivacaine (266 mg/20 mL) or ropivacaine (0.2%/20 mL).QoR-15 score at 48 hours (primary outcome),Pain scores (NRS) at rest and during ambulation,opioid consumption and rescue analgesic use,adverse events, hospital stay, and patient satisfaction were recorded

Institutions

Categories

Analgesia, Anesthesia

Licence